Low CD8 T cells predicts benefit from hypoxia-modifying therapy in bladder cancer
Authors
Smith, V.Mukherjee, D.
Tsakiroglou, A. M.
Baker, Alexander
Mistry, H.
Choudhury, A.
Hoskin, P.
Illidge, T.
West, C.
Affiliation
University of Manchester, ManchesterIssue Date
2022
Metadata
Show full item recordCitation
Smith V, Mukherjee D, Tsakiroglou AM, Baker A, Mistry H, Choudhury A, et al. Low CD8 T cells predicts benefit from hypoxia-modifying therapy in bladder cancer. Cancer Research. 2022 Jun;82(12). PubMed PMID: WOS:000892509500367.Journal
Cancer ResearchDOI
10.1158/1538-7445.AM2022-6236Additional Links
https://dx.doi.org/10.1158/1538-7445.AM2022-6236Type
Meetings and ProceedingsLanguage
enae974a485f413a2113503eed53cd6c53
10.1158/1538-7445.AM2022-6236